Assembly and activity of the proto-oncogenic cyclin D/ CDK4(6) complexes, the major driving force of G1 phase progression, is negatively regulated by a family of INK4 CDK inhibitors p16
INK4d
; cyclin D; CDK4; ubiquitin/proteasome-dependent degradation; retinoblastoma protein Progression through the G1 phase of the cell cycle, and initiation of DNA replication require neutralization of the growth-restraining capacity of the retinoblastoma tumor suppressor (pRb), whose unphosphorylated form halts the G1/S transition by sequestering the cell cycle-promoting transcription factors such as E2F. Phosphorylation of pRb by cyclin-dependent kinases (CDKs) triggers a wave of E2F-dependent synthesis of positive regulators supporting completion of G1 and initiation of DNA synthesis. This event was proposed as a molecular basis of the passage through the Restriction point, which integrates external signals with the cell cycle machinery and determines the cell's commitment to replicate the genome and complete one round of the cell cycle (reviewed in Bartek et al., 1996) . Thus, the molecular network regulating pRb phosphorylation appears to underlie a mechanism which prevents unscheduled proliferation.
Initiation of the pRb phosphorylation in mid-to-late G1 phase is critically dependent on the accumulation of the D-type cyclins and their assembly with CDK4 or CDK6 catalytic subunits (reviewed in Sherr, 1996) . The activity of these holoenzymes is further regulated by phosphorylation of the CDK, proteolysis of the cyclin subunit, and by speci®c inhibitory proteins called cyclin-dependent kinase inhibitors (CKIs) (reviewed in Lees, 1995; Sherr and Roberts, 1999) . Four members of the CDK4(6)-speci®c family of CKIs have been identi®ed to date. The founder of this so-called INK4 family, p16 INK4a , has been ®rmly established as a tumor suppressor, being frequently lost or altered in many types of human tumors (reviewed in Serrano, 1997; Ruas and Peters, 1998) . The other INK4 inhibitors were named according to their mass and order of discovery as p15
INK4b
, p18
INK4c and p19
INK4d
, respectively (Hannon and Beach, 1994; Guan et al., 1994; Hirai et al., 1995; Chan et al., 1995) . All four INK4 proteins share the ability to inhibit the kinase activity of CDK4(6) by preventing their interaction with the Dtype cyclins. Consequently, overexpression of several INK4 proteins arrests the cells in G1 phase, in a strictly pRb-dependent manner (Guan et al., 1994; Medema et al., 1995; Koh et al., 1995; Lukas et al., 1995c) . Despite the apparent redundancy in their biochemical function(s) (Hirai et al., 1995; WoÈ l and Naumann, 1999, and reviewed in Roussel, 1999) , the INK4 members dier in several parameters such as timing and tissue-speci®c patterns of expression, and inducibility by diverse external or internal stimuli. Thus, only p18
INK4c and p19 INK4d are expressed in utero, while the postnatal gradual appearance of p16
INK4a and p15
INK4b
has been implicated in triggering and/or maintenance of replicative senescence (Zindy et al., 1997; Serrano et al., 1997) . p15
INK4b seems to be unique as a mediator of the growth-restraining eects of negative cytokines such as TGF-b (Hannon and Beach, 1994) . Recently, rapid elevation of p16 INK4a was observed in human skin grafts exposed to UV light and suggested to be a part of the UV-induced DNA damage checkpoint response (Pavey et al., 1999) . One feature of p19
INK4d which appears distinct from the remaining INK4 CKIs is the pronounced periodic accumulation of its protein during the cell cycle: In synchronized mouse macrophages the protein synthesis of p19
INK4d was low in G0/G1, and peaked in S phase (Hirai et al., 1995) . Although the mRNA of p18
INK4c
was also reported to be induced by mitogens, only the kinetics of the p19
INK4d protein accumulation seemed to correlate tightly with its mRNA expression (Hirai et al., 1995) .
The cyclin D/CDK4(6) complexes perform a dual role in cell cycle regulation, via their speci®c pRbdirected kinase activity, and as a reservoir for another class of CKIs, represented by the p21 CIP1 and p27
proteins (Reynisdottir et al., 1995; Sherr and Roberts, 1999) . These CKIs inhibit a broader range of CDKs including CDK2, an activity operating downstream of CDK4 and CDK6, which appears necessary and sucient for the initiation of DNA replication (Lukas et al., 1997) . Both the kinase activity and the stoichiometric`titration' eects of cyclin D/CDK4(6) complexes help orchestrate normal somatic cell cycles (Jiang et al., 1998; McConnell et al., 1999) and, when overexpressed, may contribute to deregulated proliferation of cancer cells (Haas et al., 1997, and reviewed in Sherr, 1996) . Periodic expression of an INK4 inhibitor could signi®cantly aect the extent of productive formation of the cyclin D/CDK4(6) complexes, and thus help ensure the physiological length of G1. In this paper, we explored the oscillation of the p19
INK4d protein in human normal diploid cells and tumor-derived cell lines, and report on a previously unrecognized regulatory mode of this CKI, mediated by its proteolysis through the ubiquitin/proteasome-dependent pathway. To our knowledge, this is the ®rst evidence for ubiquitin-mediated degradation of any INK4 inhibitor, a ®nding with potentially important implications for current concepts of the somatic cell cycle control and oncogenesis.
As the dynamics of the p19 INK4d protein abundance during the cell cycle has so far been studied exclusively in murine models, we ®rst examined whether its periodicity is conserved also in human cells. In human diploid ®broblasts, synchronized by contact inhibition and subsequent re-plating to lower density, the amount of the p19
INK4d protein remained low-to-undetectable in starved cells and throughout the whole G1 period, but became progressively accumulated during S and G2/M phases ( Figure 1a ). The accumulation of the p19
INK4d protein signi®cantly lagged behind the D-type cyclins, the expression of which peaks during the G1 phase, and correlated well with the appearance of cyclin A, an established regulator of S phase progression and G2/M transition. The protein levels of the p19
INK4d speci®c interactors, CDK4 and CDK6, remained constant throughout the cell cycle ( Figure 1a ).
The next issue we addressed was whether or not the p19
INK4d protein oscillates also in continuously proliferating cells. We synchronized exponentially growing human ML-1 cells by centrifugal elutriation, and immunoblotting analysis of the individual cell fractions revealed a characteristic pattern of the p19
INK4d protein accumulation similar to ®broblasts released from quiescence. These results con®rmed that similarly to normal ®broblasts (see Figure 1a) , also in tumorderived ML-1 cells, the p19
INK4d protein was low in G1 cells and gradually accumulated as cells passed the G1/ S transition ( Figure 1b ). Densitometric analysis revealed 18-fold increase of the p19 protein in G2 fractions compared to the lowest G1 amount detected in fraction 4. On the contrary, analysis of the matched elutriated fractions showed that the protein level of p18
INK4c¯u ctuated only moderately with maximum twofold dierences between G1 and S/G2 fractions ( Figure 1b) . These data con®rmed and extended previous observations in mouse cells (Hirai et al., 1995) , and showed that in both normal and tumorderived cells of human origin, p19
INK4d protein levels dramatically oscillate, with a nadir in G0/G1, and a peak in S/G2 phases of the cell cycle.
The highly periodic accumulation of p19 INK4d but not p18
INK4c protein was intriguing since the mRNA expression of both genes¯uctuated with a very similar kinetics in a cell cycle dependent manner: Northern blot analyses demonstrated that the steady-state levels of both mRNAs were low in G1 and induced upon entry into S phase (Hirai et al., 1995, and our unpublished data) . Our observation that only the p19 INK4d protein levels closely followed the pattern of its mRNA expression could be explained if p19 INK4d during the cell cycle. (a) Skin diploid ®broblasts (BJ strain) were synchronized by incubating the con¯uent cultures for 5 days and subsequent trypsinization and re-plating into a fresh medium. After lysis at the indicated timepoints, the SDS ± PAGE-separated protein lysates (50 mg per lane) were immunoblotted with the indicated antibodies: DCS 100 to p19
INK4d (Thullberg et al., 2000) , DCS 156 to CDK4 , DCS 183 to CDK6 , a mixture of antibodies to the D-type cyclins described earlier (Lukas et al., 1994; Bartkova et al., 1998) , and rabbit antiserum to cyclin A (gift from M Pagano). Conditions for Western blotting were described (Lukas et al., 1995a) . The diagram on the top shows the degree of synchronous progression through the cell cycle as determined by¯ow cytometry. Exp.=control, asynchronously growing cells. (b) Exponentially growing ML-1 cells were synchronized by centrifugal elutriation as described (Lukas et al., 1995b) . Cell cycle distribution of individual fractions were determined by¯ow cytometry (top), and the corresponding lysates (50 mg per lane) were analysed by SDS ± PAGE and immunoblotting with antibodies against p19
INK4d (DCS 100 [Thullberg et al., 2000] ) and p18 INK4c (DCS 118 [Thullberg et al., 2000] (Parry et al., 1995; Shapiro et al., 1995; Sandhu et al., 1997 INK4d was rapidly degraded with the protein half-life between 20 and 30 min (Figure 2a) .
To directly compare the protein stability of p19
INK4d and p18
, the only two INK4 family members showing signi®cant mRNA oscillation during the cell cycle, we analysed their turnover in the human osteosarcoma cell line U-2-OS, expressing comparable levels of both of these inhibitors. Due to the lack of a suitable antibody supporting quantitative immunoprecipitation of the total cellular pool of human p18
, we assessed the protein turnover by inhibiting translation with cycloheximide (CHX). To validate such approach, we ®rst con®rmed that the protein half-lives of both p19
INK4d and p16 INK4a in cells treated with CHX were nearly identical (30 min and 6 h, respectively) to those obtained through the [
S]methionine pulse chase (Figure 2b, and data not shown). Under identical conditions, p18
INK4c remained stable with the half-life over 4 h (Figure 2b, lower panel) . We have reproduced these results using other cell lines, consistently detecting rapid degradation of p19
INK4d
, and slow protein turnover of p16
INK4a
INK4c
, and 15
INK4b (data not shown). Proteolysis of the INK4 CKIs has not been systematically studied so far, and its potential impact on the cell cycle control is unknown. In contrast, protein stability of the CIP/KIP inhibitors has been investigated thoroughly, giving rise to a concept of their ubiquitin/proteasome-mediated degradation as a fundamental mechanism coordinating G1/S transition Montagnolli et al., 1999; Sutterluty et al., 1999) . To see whether the rapid turnover of p19
INK4d is also dependent on the ubiquitin/ proteasome machinery, we inhibited the proteasome function either in exponentially growing cells or in INK4d protein (Figure 3a) , reaching nearly the maximal levels observed in later stages of the cell cycle. In contrast, LLnL treatment at the time-points enriched for S and G2 cells induced only a moderate increase of the p19
INK4d protein compared to G0 and G1 cells. (Figure 3a ), suggesting at least its partial stabilization compared to G0 and G1 phases. The residual response of S and G2 cells to LLnL could be potentially explainable by the inherent problem of incomplete synchrony in primary cells released from quiescence. Indeed,¯ow cytometry analyses con®rmed that despite signi®cant enrichment of S and G2 cells in the later time-points, we consistently detected variable proportions of`contaminating', less eciently stimulated G1 cells (see Figure 1a , and data not shown). Alternatively, we cannot exclude that some degree of the proteasome-dependent degradation of the p19 INK4d protein operates also in S and G2 phases, albeit with a somewhat lower rate compared to G1 and especially G0. In either case, proteasome-dependent degradation could signi®cantly contribute to the ®ne adjustment of of the p19
INK4d protein levels during the cell cycle, likely acting in concert with other regulatory mechanisms including periodic transcription (Hirai et al., 1995) .
To corroborate the data obtained upon proteasome inhibition, we directly tested whether p19
INK4d could be ubiquitinated and thus marked for ecient recognition by the proteasome. For that reason, we ®rst chose the U-2-OS cell line because of its high transfection eciency required for the ubiquitination assay. Indeed, co-expression of p19
INK4d together with ubiquitin lead to speci®c appearance of the high-molecular weight polyubiquitinated species in an in vivo ubiquitination assay (Figure 3b) , the formation of which was ] pulse-chase assays were performed essentially as described (Welcker et al., 1996) . Labeled p19
INK4d and p16 INK4a proteins were immunoprecipitated with speci®c monoclonal antibodies DCS 100 (Thullberg et al., 2000) and DCS 50 (Lukas et al., 1995c) , respectively. The signal of the autoradiogram (top) was quanti®ed by phosphorimager (bottom). (b) U-2-OS cells were incubated in the presence of cycloheximide (CHX; 25 mg/ml) for the indicated time and the levels of the p19
INK4d and p18 INK4c proteins were analysed by immunoblotting with monoclonal antibodies speci®ed in Figure 1(b) dramatically increased by co-expressing CDK4, the speci®c interacting partner of p19
INK4d (Figure 3b ). None of the other INK4 proteins tested in parallel showed any signi®cant ubiquitination (negative data, not shown). Taken together, our results revealed for the ®rst time, that a member of the INK4 family of CDK inhibitors could be targeted for rapid degradation by the ubiquitin/proteasome pathway. Moreover, our results suggested that for an ecient ubiquitination to occur, p19
INK4d must ®rst associate with CDK4. In order to provide direct evidence for ubiquitination of p19
INK4d
, we ®rst attempted to construct a mutant of p19
INK4d which would speci®cally uncouple the protein from modi®cation by ubiquitin ligases. Covalent attachment of the polyubiquitin chain to the target protein strictly requires lysine residues (reviewed in Ciechanover, 1998) . Inspection of p19
INK4d amino acid sequence revealed three lysines, residues 43, 62, and 91 of the human protein, respectively. Signi®cantly, none of these residues were conserved in any of the remaining three, more stable INK4 proteins. Concomitant substitution of the three lysines to arginines resulted in a p19
INK4d protein resistant to ubiquitination even upon coexpression of ectopic CDK4 which otherwise greatly potentiated ubiquitination of the wild-type protein (Figure 4a ). Subsequent analysis of single point mutations demonstrated that the lysine 62 likely represents the major ubiquitin recipient, since its substitution to arginine was sucient to dramatically reduce polyubiquitination of p19
INK4d (Figure 4a ). The observed phenomenon of CDK4-promoted ubiquitination of p19
INK4d could have at least three plausible explanations: (i) Eects of cell cycle position; (ii) Priming of p19
INK4d for ubiquitination by CDKmediated phosphorylation; and (iii) Changes in p19
INK4d protein conformation upon attachment to CDK4. It has been demonstrated that overproduction of the INK4 inhibitors imposes a G1 arrest in cells harboring wild-type pRb, such as U-2-OS cells used in our in vivo ubiquitination experiments (Lukas et al., 1995c) . Co-expression of CDK4 can revert such arrest via sequestration of the excessive INK4 protein(s) (Koh et al., 1995) . Alternatively, S phase entry in the G1 arrested, INK4-overexpressing cells can be rescued by ectopic expression of cyclin E/CDK2, which physiologically operates downstream of pRb phosphorylation (Alevizopoulos et al., 1997; Lukas et al., 1997) . To test the potential eect of cell-cycle position as explanation of the CDK4 impact on p19
INK4d ubiquitination, we tested the ability of p19
INK4d to become ubiquitinated under either of the above conditions allowing cell cycle progression in the presence of ectopically expressed p19
. Multiparameter¯ow cytometry con®rmed that co-expression of either CDK4 or cyclin E/CDK2 restored DNA replication in cells overexpressing p19
INK4d (data not shown). However, only CDK4 was able to stimulate ubiquitination of p19
INK4d (Figure 4b ), ruling out the indirect eect of cell cycle progression. To independently con®rm these results, we also studied p19 or to another CDK4 mutant, de®cient in its catalytic activity yet capable of interacting with the INK4 proteins (Van den Heuvel and Harlow, 1993, and our unpublished observation) (Figure 4c ). Western blotting analysis performed in parallel con®rmed that all CDK4 versions were expressed to similar levels (Figure 4d) . Collectively, our results are consistent with the interpretation that the direct interaction with free, presumably monomeric CDK4 determines productive ubiquitination and subsequent rapid degradation of p19
. Contrary to the tremendous progress in our knowledge about the molecular network controlling protein turnover of the p27
Kip1 CDK inhibitor (reviewed in Amati and Vlach, 1999) , regulation of protein stability of the INK4 CKIs has remained unexplored despite the evidence implicating accumulation of these inhibitors in fundamental biological processes such as cellular ∆ ∆ Figure 4 Association with CDK4 promotes p19
INK4d ubiquitination. (a) Wild-type p19 INK4d or the indicated lysine-to-arginine (R) mutants were transiently expressed together with CDK4 and ubiquitin in U-2-OS cells (trR, triple substitution of lysines 43, 62, and 91 to arginine). The in vivo ubiquitination assay was performed essentially as described in Figure 3(b) with the exception that ubiquitin was expressed from the pCW7 plasmid (gift from C Ward) which gives lower amount of ubiquitin compared to pCMVneo/bam expression pasmid used in Figure 3 . In vivo ubiquitination assay was performed in SAOS-2 cells as described in (a) and (b). (d) Equal expression levels of the HA-tagged CDK4 wild-type and mutants used in (c) were veri®ed by imunoblotting with the monoclonal antibody DCS 156 senescence or cell-cycle arrest in response to negative
